TPNA10168 is an Nrf2 activator that activates the Keap1-Nrf2-ARE pathway; it exhibits neuroprotective effects against oxidative stress-induced damage; it significantly reduces the transcription of inflammatory genes, including TNF-α, IL-1β, IL-6, and iNOS; it can be used in research on anti-inflammatory and neurological disorders.